Funding The study was supported by a Start-Up Grant from University Grants Commission (UGC) Grant No
Unlike the supplement industry's usual suspects, which tend to promise everything and deliver little, GHK-Cu has built its reputation the hard way: through peer-reviewed research, clinical trials, and reproducible results across multiple applications
For compounding pharmacies like Empower, telehealth giant Hims & Hers and a slew of others, which can concoct drugs specifically for individual patients, that puts a potential multi-billion-dollar market within reach
Two classes of anti-senescence compounds have been reported so far: Quercetin/Dasatinib, either alone or in combination(Zhu et al., 2015), and the pan-BCL inhibitors ABT-263/737(Chang et al., 2016